MAXCYTE, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

MAXCYTE, INC. reported Cash And Cash Equivalents At Carrying Value of $20.07 million for the year ending 2025.

  • MAXCYTE, INC. showed a decrease of -28.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from MAXCYTE, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), MAXCYTE, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 7.0%.
  • Historical annual values: Fiscal year 2025: $20.07 million | Fiscal year 2024: $27.88 million | Fiscal year 2023: $46.51 million | Fiscal year 2022: $11.07 million | Fiscal year 2021: $47.78 million | Fiscal year 2020: $18.76 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: